Precigen logo

Precigen share price today

(PGEN)

Precigen share price is $0.71 & ₹60.23 as on 13 Dec 2024, 2.30 'hrs' IST

$0.71

-0.04

(-5.09%)

Market is closed - opens 8 PM, 13 Dec 2024

View live Precigen share price in Dollar and Rupees. Guide to invest in Precigen from India. Also see the sentimental analysis on Indian investors investing in Precigen. Get details on the Indian mutual funds that are investing in Precigen. Get Analyst recommendations and forecasts along with all the Precigen's financials.

Precigen share price movements

  • $0.71
    $0.75

    Day's Volatility :5.57%

  • $0.71
    $1.93

    52 Weeks Volatility :63.21%

Precigen Returns

PeriodPrecigen IncSector (Health Care)Index (Russel 2000)
3 Months
-32.19%
-9.7%
0.0%
6 Months
-56.32%
-3.4%
0.0%
1 Year
-43.49%
3.7%
0.0%
3 Years
-79.83%
3.8%
-18.9%

Precigen Key Statistics

in dollars & INR

Previous Close
$0.7502
Open
$0.75
Today's High
$0.7519
Today's Low
$0.71
Market Capitalization
$219.7M
Today's Volume
$1.1M
52 Week High
$1.93
52 Week Low
$0.71
Revenue TTM
$4.4M
EBITDA
$-88.6M
Earnings Per Share (EPS)
$-0.54
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-129.32%

How to invest in Precigen from India?

It is very easy for Indian residents to invest directly in Precigen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Precigen stock in both rupees (INR) and dollars (USD). Search for Precigen or PGEN on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Precigen or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Precigen shares which would translate to 1.195 fractional shares of Precigen as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Precigen

-7%

Period: Sep 13, 2024 to Dec 12, 2024. Change in 30 Days versus previous period

Search volume for Precigen on INDmoney from India has reduced in the last 30 days as on Dec 13, 2024. -7% less investors are searching Precigen in the last 30 days versus the previous period.

Global Institutional Holdings in Precigen

  • Patients Capital Management LLC

    6.12%

  • Adage Capital Partners Gp LLC

    3.71%

  • BlackRock Inc

    3.50%

  • Vanguard Group Inc

    2.84%

  • Iridian Asset Management LLC

    1.29%

  • Geode Capital Management, LLC

    1.11%

Analyst Recommendation on Precigen

Buy

    81%Buy

    9%Hold

    9%Sell

Based on 11 Wall street analysts offering stock ratings for Precigen(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
2
Sell
1
1
0

Analyst Forecast on Precigen

What analysts predicted

Upside of 745.07%

Current:

$0.71

Target:

$6.00

Insights on Precigen

  • Price Movement

    In the last 1 month, PGEN stock has moved down by -22.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 717.0K → 953.0K (in $), with an average increase of 24.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -58.79M → -23.97M (in $), with an average increase of 145.2% per quarter
  • PGEN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.9% return, outperforming this stock by 77.5%
  • PGEN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 31.6% return, outperforming this stock by 112.4%
  • Price to Sales

    ForPGEN every $1 of sales, investors are willing to pay $39.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.8 for every $1 of sales.

Precigen Financials in INR & Dollars

FY18Y/Y Change
Revenue
$160.6M
↓ 30.48%
Net Income
$-509.3M
↑ 335.26%
Net Profit Margin
-317.2%
↓ 266.54%
FY19Y/Y Change
Revenue
$90.7M
↓ 43.5%
Net Income
$-207.8M
↓ 59.21%
Net Profit Margin
-229.0%
↑ 88.2%
FY20Y/Y Change
Revenue
$103.2M
↑ 13.73%
Net Income
$-103.8M
↓ 50.05%
Net Profit Margin
-100.58%
↑ 128.42%
FY21Y/Y Change
Revenue
$103.9M
↑ 0.67%
Net Income
$-96.8M
↓ 6.75%
Net Profit Margin
-93.16%
↑ 7.42%
FY22Y/Y Change
Revenue
$26.9M
↓ 74.09%
Net Income
$-79.8M
↓ 17.56%
Net Profit Margin
-296.47%
↓ 203.31%
FY23Y/Y Change
Revenue
$6.2M
↓ 76.87%
Net Income
$-95.9M
↑ 20.22%
Net Profit Margin
-1.5K%
↓ 1244.16%
Q2 FY23Q/Q Change
Revenue
$1.8M
↓ 4.54%
Net Income
$-20.3M
↓ 10.62%
Net Profit Margin
-1.1K%
↑ 78.28%
Q3 FY23Q/Q Change
Revenue
$16.7M
↑ 846.35%
Net Income
$87.4M
↓ 530.04%
Net Profit Margin
522.54%
↑ 1672.46%
Q4 FY23Q/Q Change
Revenue
$1.2M
↓ 92.66%
Net Income
$-33.1M
↓ 137.83%
Net Profit Margin
-2.7K%
↓ 3214.4%
Q1 FY24Q/Q Change
Revenue
$1.1M
↓ 13.27%
Net Income
$-23.7M
↓ 28.19%
Net Profit Margin
-2.2K%
↑ 462.94%
Q2 FY24Q/Q Change
Revenue
$717.0K
↓ 32.68%
Net Income
$-58.8M
↑ 147.67%
Net Profit Margin
-8.2K%
↓ 5970.8%
Q3 FY24Q/Q Change
Revenue
$953.0K
↑ 32.91%
Net Income
$-24.0M
↓ 59.22%
Net Profit Margin
-2.5K%
↑ 5683.67%
FY18Y/Y Change
Total Assets
$716.2M
↓ 15.43%
Total Liabilities
$337.5M
↑ 12.37%
FY19Y/Y Change
Total Assets
$455.8M
↓ 36.36%
Total Liabilities
$384.1M
↑ 13.81%
FY20Y/Y Change
Total Assets
$314.6M
↓ 30.98%
Total Liabilities
$247.4M
↓ 35.58%
FY21Y/Y Change
Total Assets
$359.9M
↑ 14.39%
Total Liabilities
$252.5M
↑ 2.06%
FY22Y/Y Change
Total Assets
$216.0M
↓ 39.98%
Total Liabilities
$89.7M
↓ 64.47%
FY23Y/Y Change
Total Assets
$151.0M
↓ 30.07%
Total Liabilities
$32.5M
↓ 63.73%
Q2 FY23Q/Q Change
Total Assets
$207.5M
↓ 14.08%
Total Liabilities
$41.3M
↓ 28.04%
Q3 FY23Q/Q Change
Total Assets
$190.7M
↓ 8.11%
Total Liabilities
$43.0M
↑ 4.1%
Q4 FY23Q/Q Change
Total Assets
$151.0M
↓ 20.79%
Total Liabilities
$41.6M
↓ 3.18%
Q1 FY24Q/Q Change
Total Assets
$134.8M
↓ 10.72%
Total Liabilities
$37.8M
↓ 9.16%
Q2 FY24Q/Q Change
Total Assets
$73.2M
↓ 45.75%
Total Liabilities
$30.0M
↓ 20.72%
Q3 FY24Q/Q Change
Total Assets
$83.5M
↑ 14.1%
Total Liabilities
$28.1M
↓ 6.31%
FY18Y/Y Change
Operating Cash Flow
$-124.2M
↑ 19.3%
Investing Cash Flow
$-151.2M
↓ 244.93%
Financing Cash Flow
$309.8M
↑ 7131.44%
FY19Y/Y Change
Operating Cash Flow
$-135.9M
↑ 9.41%
Investing Cash Flow
$86.9M
↓ 157.44%
Financing Cash Flow
$8.1M
↓ 97.37%
FY20Y/Y Change
Operating Cash Flow
$-77.0M
↓ 43.34%
Investing Cash Flow
$27.8M
↓ 68.02%
Financing Cash Flow
$32.7M
↑ 301.88%
FY21Y/Y Change
Operating Cash Flow
$-55.8M
↓ 27.59%
Investing Cash Flow
$-74.5M
↓ 368.33%
Financing Cash Flow
$121.2M
↑ 270.55%
FY22Y/Y Change
Operating Cash Flow
$-65.0M
↑ 16.63%
Investing Cash Flow
$226.4M
↓ 403.75%
Financing Cash Flow
$-155.3M
↓ 228.14%
Q2 FY23Q/Q Change
Operating Cash Flow
$-15.8M
↓ 14.25%
Investing Cash Flow
$23.5M
↓ 146.63%
Financing Cash Flow
$-14.6M
↓ 133.02%

Precigen Technicals Summary

Sell

Neutral

Buy

Precigen is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Precigen Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Precigen Inc
-22.25%
-56.32%
-43.49%
-79.83%
-88.59%
Regeneron Pharmaceuticals, Inc.
-7.88%
-28.51%
-15.41%
10.43%
97.06%
Biontech Se
8.26%
31.07%
16.1%
-56.39%
244.83%
Alnylam Pharmaceuticals, Inc.
-7.31%
52.91%
31.52%
32.05%
104.18%
Vertex Pharmaceuticals Incorporated
-6.16%
-3.46%
14.15%
121.81%
111.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Precigen Inc
NA
NA
NA
-0.46
-1.29
-0.42
NA
0.48
Regeneron Pharmaceuticals, Inc.
19.12
19.12
1.15
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.12
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.23
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Precigen Inc
Buy
$219.7M
-88.59%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$84.9B
97.06%
19.12
33.61%
Biontech Se
Buy
$28.6B
244.83%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.8B
104.18%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
111.44%
32.84
-4.51%

About Precigen

precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Organization
Precigen
Employees
202
CEO
Mr. Randal J. Kirk J.D.
Industry
Health Technology

Management People of Precigen

NameTitle
Mr. Randal J. Kirk J.D.
Executive Chairman
Dr. Helen Sabzevari MPH, Ph.D.
President, CEO & Director
Mr. Harry Thomasian Jr.
Chief Financial Officer
Mr. Rutul R. Shah
Chief Operating Officer
Mr. Donald P. Lehr J.D., Ph.D.
Chief Legal Officer & Corporate Secretary
Mr. Jeffrey Thomas Perez J.D.
Senior Vice President of Intellectual Property Affairs
Mr. Steven Harasym
VP & Head of Investor Relations
Mr. Rob Russell
VP & Head of Human Resources
Dr. Douglas E. Brough Ph.D.
Senior VP & Head of Research
Dr. Bryan T. Butman Ph.D.
Senior VP & Head of CMC

Important FAQs about investing in Precigen from India :

What is Precigen share price today?

Precigen (PGEN) share price today is $0.71.

Can Indians buy Precigen shares?

Yes, Indians can invest in the Precigen (PGEN) from India.

With INDmoney, you can buy Precigen at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Precigen at zero transaction cost.

How can I buy Precigen shares from India?

It is very easy to buy Precigen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Precigen be purchased?

Yes, you can buy fractional shares of Precigen with INDmoney app.

What are the documents required to start investing in Precigen stocks?

To start investing in Precigen, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Precigen

Today’s highest price of Precigen (PGEN) is $0.75.

Today’s lowest price of Precigen (PGEN) is $0.71.

What is today's market capitalisation of Precigen

Today's market capitalisation of Precigen PGEN is 219.7M

What is the 52 Week High and Low Range of Precigen

  • 52 Week High

    $1.93

  • 52 Week Low

    $0.71

How much percentage Precigen is down from its 52 Week High?

Precigen (PGEN) share price is $0.71. It is down by 63.21% from its 52 Week High price of $1.93.

How much percentage Precigen is up from its 52 Week low?

Precigen (PGEN) share price is $0.71. It is up by 0% from its 52 Week Low price of $0.71.

What are the historical returns of Precigen?

  • 1 Month Returns

    -22.25%

  • 3 Months Returns

    -56.32%

  • 1 Year Returns

    -43.49%

  • 5 Years Returns

    -88.59%

Who is the Chief Executive Officer (CEO) of Precigen

Mr. Randal J. Kirk J.D. is the current Chief Executive Officer (CEO) of Precigen.